PURPOSE: To determine whether there is an increased risk to the corneal endothelium
when mitomycin C (MMC) is administered after photorefractive keratectomy (PRK). DESIGN …

PURPOSE: To elucidate the distinct role of the intraoperative use of mitomycin C (MMC) on
endothelial cell density after photorefractive keratectomy (PRK) in human eyes. DESIGN …

Purpose To evaluate short-term changes in central corneal endothelial cell density and
morphology after photorefractive keratectomy (PRK) with mitomycin-C (MMC) 0.02% in …

PURPOSE: To evaluate the effect of intraoperative use of mitomycin-C (MMC) on the corneal
endothelium during excimer laser photorefractive keratectomy (PRK). SETTING: Vanak Eye …

Purpose: This brief review examines both basic science and clinical studies to evaluate the
potential impact on the health of the corneal endothelium of mitomycin C (MMC) usage …

PURPOSE: To evaluate the efficacy and safety of photorefractive keratectomy (PRK) with
intraoperative application of mitomycin-C (MMC). SETTING: Yonsei Eye Center, Seoul …

PURPOSE: To investigate the effects of mitomycin-C (MMC) on epithelial and keratocyte cell
kinetics after photorefractive keratectomy (PRK) using an in vitro human cornea model …

Purpose: To evaluate the effect of topical mitomycin C (MMC) after myopic photorefractive
keratectomy (PRK) on epithelialization and predictability. Methods: Prospective …

PURPOSE: To evaluate the safety and efficacy of 5 seconds of mitomycin-C (MMC)
application during photorefractive keratectomy (PRK) for low myopia. SETTING: Basir Eye …

ABSTRACT PURPOSE: To evaluate the potential effect of topical mitomycin C (MMC) on the
corneal endothelium of myopic patients undergoing photorefractive keratectomy (PRK) …